European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Ulf Landmesser, M John Chapman, Michel Farnier, Baris Gencer, Stephan Gielen, G. Kees Hovingh, Thomas F. Lüscher, David Sinning, Lale Tokgözoğlu, Olov Wiklund, Jose Luis Zamorano, Fausto J. Pinto, Alberico L Catapano, European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalEuropean Heart Journal
Publication statusE-pub ahead of print - Oct 27 2016


  • Journal Article

Cite this